TENAX THERAPEUTICS, INC. Operating Lease Liability
TENAX THERAPEUTICS, INC. (TENX) had Operating Lease Liability of $0 as of 2023-12-31, per its 10-K filed 2024-03-28.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2025-03-25
- 2023-12-31: Operating Lease, Liability $0.00.
- 2023-02-08: Operating Lease, Liability $0.00.
- 2022-12-31: Operating Lease, Liability $183.59K.
- 2022-09-30: Operating Lease, Liability $211.59K.
| Period end | Operating Lease, Liability |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2023-02-08 | $0.00 10-K · filed 2025-03-25 |
| 2022-12-31 | $183.59K 10-K · filed 2024-03-28 |
| 2022-09-30 | $211.59K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $239.04K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $265.17K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $290.78K 10-K · filed 2023-03-31 |
| 2021-09-30 | $315.89K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $340.50K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $30.74K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $60.38K 10-K · filed 2022-03-29 |
| 2020-09-30 | $89.18K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $117.42K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $145.09K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $171.73K 10-K/A · filed 2021-04-16 |
| 2019-09-30 | $197.60K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $222.96K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $247.82K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |